Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023;16(1):448-457.
doi: 10.22037/ghfbb.v16i1.2685.

Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis

Teodoro J Oscanoa  1   2   3 , Xavier Vidal  4 , Julio Luque  2 , Dante I Julca  1 , Roman Romero-Ortuno  5   6
Affiliations
Review

Hepatotoxicity induced by isoniazid in patients with latent tuberculosis infection: a meta-analysis

Teodoro J Oscanoa et al. Gastroenterol Hepatol Bed Bench. 2023.

Abstract

Aim: The aim of the present study was to conduct a meta-analysis of the frequency of isoniazid-induced liver injury (INH-ILI) in patients receiving isoniazid (INH) preventative therapy (IPT).

Background: The frequency of hepatotoxicity (drug-induced liver injury: DILI) of antituberculosis drugs has been studied, especially when INH, rifampin, and pyrazinamide are co-administered. However, little is known about the frequency of DILI in patients with latent tuberculosis infection (LTBI), where IPT is indicated.

Methods: We searched PubMed, Google Scholar, and the Cochrane Database of Systematic Reviews for studies reporting the frequency of INH-ILI in patients with IPT using one or more diagnostic indicators included in the criteria of the DILI Expert Working Group.

Results: Thirty-five studies comprising a total of 22,193 participants were included. The overall average frequency of INH-ILI was 2.6% (95% CI, 1.7-3.7%). The mortality associated with INH-DILI was 0.02% (4/22193). Subgroup analysis revealed no significant differences in the frequency of INH-ILI in patients older or younger than 50 years, children, patients with HIV, candidates for liver, kidney, or lung transplant, or according to the type of study design.

Conclusion: The frequency of INH-ILI in patients receiving IPT is low. Studies on INH-ILI are needed where the current DILI criteria are used.

Keywords: Adverse drug reaction; Drug induced liver injury; Isoniazid; Latent tuberculosis; Liver injury.

PubMed Disclaimer

Conflict of interest statement

The authors certify that they have no conflict of interests.

Figures

Figure 1
Figure 1
Study screening Flowchart
Figure 2
Figure 2
Forest plot of frequencies of isoniazid-induced liver injury (INH-ILI) in patients with latent tuberculosis infection (LTBI) receiving Isoniazid Preventive Therapy (IPT)
See this image and copyright information in PMC

References

    1. Unissa AN, Subbian S, Hanna LE, Selvakumar N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evol. 2016;45:474–492. - PubMed
    1. Licence: CC BY-NC-SA 3.0 IGO. n.d, authors. WHO consolidated guidelines on tuberculosis. Module 1: prevention – tuberculosis preventive treatment. Geneva: World Health Organization; 2020. - PubMed
    1. Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WCM, van der Ven AJAM, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review. J Gastroenterol Hepatol. 2008;23:192–202. - PubMed
    1. Mølhave M, Wejse C. Historical review of studies on the effect of treating latent tuberculosis. Int J Infect Dis. 2020;92:31–36. - PubMed
    1. Saukkonen JJ, Cohn DL, Jasmer RM, Schenker S, Jereb JA, Nolan CM, et al. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. 2006;174:935–952. - PubMed

LinkOut - more resources